Lead sponsor
Chugai Pharmaceutical
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
28
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease PatientsAlzheimer's diseasePh 1Completed28